Our customer service representatives are available 24 hours a day, from Monday to Sunday.
In the rapidly evolving cosmetics industry, substantiating product claims with credible, science-driven evidence is no longer optional—it is a regulatory and market imperative. At Alfa Chemistry, we offer a comprehensive portfolio of in vitro efficacy evaluation services designed to help cosmetic manufacturers and brand owners validate product performance using well-characterized cell-based and biochemical assays. Our strictly laboratory-based approach eliminates the need for clinical trials while delivering robust, reproducible data that supports product development, marketing claims, and regulatory submissions.
Our in vitro testing platforms span a wide range of cosmetic efficacy endpoints, from anti-aging and skin brightening to barrier repair and scalp care. Each assay is conducted under controlled conditions by experienced scientists using validated protocols, ensuring that your products are evaluated with the highest standards of scientific rigor and reproducibility.
Our in vitro efficacy evaluation services support a broad spectrum of cosmetic product types and claims, including but not limited to:
Aging is a multifactorial process involving the progressive loss of dermal matrix integrity. Our in vitro anti-aging assays are designed to quantify the ability of cosmetic actives and finished formulations to counteract key molecular drivers of skin aging, providing clear evidence for anti-wrinkle, firming, and rejuvenation claims.
| Test Method | Description & Claims Supported |
|---|---|
| Fibroblast Collagen Synthesis Assay | Quantification of type I collagen production in human dermal fibroblasts via ELISA or immunofluorescence staining. Supports claims: anti-wrinkle, firming, improved skin elasticity. |
| Elastase Inhibition Assay | Measurement of inhibitory activity against elastase, the enzyme responsible for elastin degradation. Supports claims: anti-aging, skin firmness preservation, wrinkle reduction. |
| Matrix Metalloproteinase (MMP) Inhibition | Assessment of a test article's capacity to suppress MMP-1 expression in UV-stressed fibroblasts. Supports claims: photoaging protection, dermal matrix preservation. |
| Senescence-Associated β-Galactosidase Assay | Evaluation of cellular senescence markers in fibroblasts exposed to oxidative stress. Supports claims: anti-aging, delaying cellular aging. |
Hyperpigmentation remains one of the most common cosmetic concerns worldwide. Our in vitro whitening and brightening assays evaluate the ability of cosmetic ingredients to intervene at multiple stages of melanin synthesis and transfer, generating data to substantiate whitening, spot-correcting, and tone-evening claims.
| Test Method | Description & Claims Supported |
|---|---|
| Tyrosinase Activity Inhibition (B16 Melanoma Model) | Measurement of intracellular tyrosinase activity in B16 melanoma cells after treatment. Supports claims: whitening, brightening, melanin synthesis inhibition. |
| Melanin Content Quantification | Direct spectrophotometric measurement of total melanin content in B16 cells following test article exposure. Supports claims: depigmenting, spot reduction, skin tone lightening. |
| Melanin Transfer Inhibition (Keratinocyte Co-Culture) | Assessment of melanosome transfer from melanocytes to keratinocytes using a co-culture system. Supports claims: brightening, prevention of pigmentation spread, even skin tone. |
Oxidative stress and glycation are two interrelated processes that accelerate skin aging and contribute to dullness, loss of elasticity, and uneven tone. Our antioxidant and anti-glycation assays provide quantitative evidence for claims related to free radical defense, anti-pollution benefits, and anti-glycation effects.
| Test Method | Description & Claims Supported |
|---|---|
| DPPH / ABTS Radical Scavenging Assay | Spectrophotometric quantification of free radical neutralizing capacity using stable radical chromogens. Supports claims: antioxidant, free radical scavenging. |
| Intracellular ROS Clearance (DCFH-DA Fluorescence) | Measurement of reactive oxygen species reduction in living cells using the DCFH-DA fluorescent probe. Supports claims: antioxidant, anti-pollution, cellular protection. |
| Anti-Glycation Assay (Glycated-BSA / Fluorescent AGEs) | Evaluation of the ability to inhibit advanced glycation end-product (AGE) formation in a BSA-glucose model system. Supports claims: anti-glycation, anti-sallowness, anti-yellowing. |
| Cellular Anti-Glycation Assay | Assessment of glycation inhibition at the cellular level using fibroblast or keratinocyte models. Supports claims: anti-glycation, preservation of skin radiance. |
Inflammation is a central mediator in sensitive skin conditions, redness, and irritation. Our in vitro anti-inflammatory assays use well-established macrophage models to quantify the modulation of key inflammatory mediators, providing robust support for soothing, calming, and sensitive-skin-compatible claims.
| Test Method | Description & Claims Supported |
|---|---|
| Nitric Oxide (NO) Inhibition Assay | Measurement of NO production in LPS-stimulated RAW264.7 macrophages via Griess reaction. Supports claims: soothing, anti-inflammatory, calming. |
| Prostaglandin E2 (PGE2) Quantification | ELISA-based measurement of PGE2 levels in LPS-induced macrophage culture supernatants. Supports claims: anti-irritation, redness relief. |
| Pro-Inflammatory Cytokine Profiling (IL-6, TNF-α) | Quantitative detection of IL-6 and TNF-α secretion in stimulated macrophages. Supports claims: sensitive skin compatible, soothing, anti-inflammatory. |
Adequate hydration and an intact skin barrier are fundamental to healthy, resilient skin. Our in vitro moisturizing and barrier function assays employ ex vivo skin models and advanced analytical techniques to quantify the ability of cosmetic products to reduce water loss, enhance hydration, and strengthen the epidermal barrier.
| Test Method | Description & Claims Supported |
|---|---|
| Ex Vivo Transepidermal Water Loss (TEWL) Measurement | Assessment of water vapor flux across ex vivo skin (porcine or reconstructed 3D skin models) after product application. Supports claims: moisturizing, barrier strengthening, reduces water loss. |
| Stratum Corneum Hydration (Capacitance Method) | Measurement of electrical capacitance of the stratum corneum as an indicator of water content. Supports claims: hydration, long-lasting moisture. |
| Filaggrin / Loricrin Expression (Immunohistochemistry) | Detection and quantification of key barrier proteins (filaggrin, loricrin) in 3D epidermal models via immunohistochemical staining. Supports claims: barrier repair, strengthens skin barrier, promotes natural moisturizing factor. |
Hair thinning and loss are complex concerns driven by hormonal, nutritional, and follicular factors. Our in vitro hair-related assays are designed to evaluate the potential of cosmetic actives to stimulate dermal papilla cell activity, inhibit the hormonal pathway linked to hair loss, and promote a pro-growth microenvironment around the hair follicle.
| Test Method | Description & Claims Supported |
|---|---|
| Dermal Papilla Cell Proliferation Assay | Measurement of human dermal papilla cell viability and proliferation after treatment with test articles. Supports claims: anti-hair loss, promotes hair growth, follicle activation. |
| 5α-Reductase Inhibition Assay | Enzymatic assay to evaluate the inhibitory effect on 5α-reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT). Supports claims: anti-hair loss, DHT-related hair thinning prevention. |
| Vascular Endothelial Growth Factor (VEGF) Detection | Quantification of VEGF secretion in dermal papilla cells, a key growth factor supporting perifollicular angiogenesis. Supports claims: promotes hair growth, strengthens hair follicles. |
Dandruff is closely associated with the proliferation of Malassezia species on the scalp. Our in vitro anti-dandruff assays evaluate the antimicrobial and anti-biofilm activity of cosmetic ingredients against Malassezia, providing evidence for anti-dandruff and scalp microecology regulation claims.
| Test Method | Description & Claims Supported |
|---|---|
| Malassezia Zone of Inhibition Assay | Agar diffusion test measuring the diameter of the growth inhibition zone against Malassezia strains. Supports claims: anti-dandruff, anti-Malassezia, scalp cleansing. |
| Biofilm Formation Inhibition Assay | Quantitative assessment of the ability to prevent or disrupt Malassezia biofilm formation using crystal violet staining. Supports claims: scalp microecology regulation, long-lasting dandruff control. |
Oral care products require substantiation of their functional benefits under simulated oral cavity conditions. Our in vitro oral care assays employ mineralized tissue models and microbial systems to evaluate remineralization, anti-adhesion, and acid production inhibition, supporting anti-caries and anti-plaque claims without the need for clinical trials.
| Test Method | Description & Claims Supported |
|---|---|
| Hydroxyapatite (HAP) Remineralization Assay | Simulated demineralization/remineralization cycling on hydroxyapatite substrates to evaluate mineral deposition and surface hardness recovery. Supports claims: anti-caries, remineralization, enamel repair. |
| Acquired Pellicle Protein Inhibition (Anti-Adhesion) | Assessment of the ability to inhibit protein adsorption and bacterial adhesion to hydroxyapatite surfaces. Supports claims: anti-plaque, anti-tartar, reduces bacterial adhesion. |
| Acid Production Inhibition (Streptococcus mutans) | Measurement of pH changes in Streptococcus mutans cultures to evaluate the inhibition of acidogenesis. Supports claims: anti-caries, acid neutralization, oral pH balance. |
A: Our in vitro platform accommodates a wide variety of sample types, including pure active ingredients, complex botanical extracts, diluted formulations, and finished cosmetic products. Samples are typically prepared as solutions or suspensions at concentrations relevant to the intended use level. We recommend consulting our scientific team during the experimental design phase to determine the optimal sample preparation protocol for your specific material.
A: In vitro data provide mechanistic evidence that a cosmetic ingredient or formulation can produce a specific biological effect under controlled laboratory conditions. When combined with appropriate formulation context and supporting literature, these results form a scientifically sound basis for product performance claims. Our reports include detailed methodological descriptions, statistical analyses, and interpretive summaries designed to facilitate regulatory review and marketing communication.
A: Turnaround times vary depending on the number and type of assays requested. Single-endpoint studies may be completed within 2–4 weeks, while multi-claim evaluation programs generally require 4–8 weeks. We provide estimated timelines during the project proposal stage and work closely with clients to accommodate accelerated schedules where feasible.
A: Yes. Our analytical and cell-based platforms are compatible with a broad range of ingredient types, including novel synthetic compounds, peptides, fermented ingredients, and complex natural extracts. We routinely perform solubility and cytotoxicity screening as part of method development to ensure that your proprietary actives are tested under appropriate and non-cytotoxic conditions.
A: Absolutely. In addition to our standard assay portfolio, our R&D team has extensive experience in developing bespoke in vitro models for novel or niche efficacy claims. We work collaboratively with clients to design and validate custom assays that address specific mechanistic hypotheses or unique product positioning requirements.
If you have any questions, please contact us. You will get a satisfactory answer.
